AWM
NVCT icon

Austin Wealth Management’s Nuvectis Pharma NVCT Stock Holding History

Austin Wealth Management’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$154K Hold
20,125
– – 0.04% 117
2025
Q4 		$178K Hold
20,125
– – 0.03% 161
2025
Q3 		$119K Hold
20,125
– – 0.02% 159
2025
Q2 		$140K Sell
20,125
-20,125
-50% -$183K 0.02% 136
2025
Q1 		$441K Buy
+40,250
New +$290K 0.09% 82

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Austin Wealth Management's NVCT Position: Q1 2026 in Review

Austin Wealth Management held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 20,125 shares worth $154K. The position accounts for 0.04% of the portfolio, ranked #117.

Austin Wealth Management first reported a position in NVCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $441K in Q1 2025. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Austin Wealth Management held 20,125 shares of Nuvectis Pharma worth $154K as of Q1 2026.
  • Austin Wealth Management left its Nuvectis Pharma share count unchanged in Q1 2026.
  • Nuvectis Pharma made up 0.04% of Austin Wealth Management's portfolio in Q1 2026, its #117 holding.
  • Austin Wealth Management first reported a position in Nuvectis Pharma in Q1 2025 and has held it in 5 quarters since.
  • Austin Wealth Management's Nuvectis Pharma position peaked at $441K in Q1 2025.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Austin Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.